"The TSMC of the Wet Lab"

The Infrastructure for the
AI Drug Discovery Era.

Eliminating the 2–3 week biological recovery tax by delivering ready-to-assay, adherent human iPSC platforms in standardized microwell plates, natively paired with verified Digital Twin metadata APIs.

Aligned with FDA Modernization Act 2.0 • 21 CFR Part 11 Audit Provenance

The "Garbage In" Crisis

Predictive AI models are failing to converge due to a fundamental biological data crisis. Legacy frozen cryo-vials introduce high batch variance and force screening teams to pay a 2–3 week "Recovery Tax" manually thawing, plating, and recovering damaged cells.

This supply-chain noise prevents active-learning algorithms from separating therapeutic signal from technical artifacts, fueling $28B in annual preclinical reproducibility waste.

$28B
Annual Preclinical Reproducibility Waste Driven by Legacy Cryo-Vial Supply-Chain Noise

The TSMC Delivery Model

Ideal-X BioFoundry decouples biological manufacturing from assay design. We replace artisanal cell culturing with an automated foundry delivering ready-to-assay plates calibrated for computational drug discovery.

01 / PHYSICAL LAYER

Live-Ship Platform

Delivering fully adherent, assay-ready cultures directly to your bench. Our proprietary transport system isolates fragile cell models from physical shipping stress while maintaining continuous multi-day temperature control.

02 / BIOLOGICAL ENGINE

Two-Track Substrate

Substrate-agnostic biomanufacturing delivering Track A (Standard Catalog) platforms—launching with standardized human cortical neurons for high-throughput screening velocity (<5% CV)—alongside bespoke Track B (Custom Foundry) protocols for physiologically mature, custom disease models.

03 / DIGITAL LAYER

Digital Twin & Zero IP Leakage

Every plate arrives natively bundled with a structured metadata payload (JSON/Parquet) containing 40+ morphometric embeddings and continuous environmental transit telemetry. Operates via a strict one-way push: we validate input quality without ever viewing your proprietary compound structures.

Transit Durability & Quality Release

Conventional transit dynamics cause catastrophic monolayer lifting in sensitive adherent human cells. Rigorously validated across commercial transcontinental logistics routes using highly sensitive adherent human neurons, the Ideal-X BioFoundry platform empirically demonstrates unbroken structural, metabolic, and functional integrity.

>95%
Post-Transit Cell Viability
<1%
Monolayer Delamination Across Wells
HTS-Ready
Statistical Screening Parity (Z' > 0.50)

Initiate the "Split-Plate Challenge"

Evaluate our live, ready-to-assay microplates directly on your bench. We ship customized plates to benchmark head-to-head against your internal cryo-thawed controls—validating superior assay sensitivity with zero procurement friction.